Identification of the KIF and MCM protein families as novel targets for combination therapy with CDK4/6 inhibitors in bladder cancer [0.03%]
膀胱癌中使用CDK4/6抑制剂联合疗法识别新的靶标KIF和MCM蛋白家族
Julian Kositza,Julia Nguyen,Ting Hong et al.
Julian Kositza et al.
CDK4/6 inhibitors have proven their potency for the treatment of cancer but only in combination with hormone or targeted therapies. The aim of this study was the identification of molecules that are involved in response mechanisms to CDK4/6...
Renal cell carcinoma with tumor thrombus: A review of relevant anatomy and surgical techniques for the general urologist [0.03%]
肾细胞癌合并瘤栓:泌尿外科医师的相关解剖及手术技术综述
Abraham L Almatari,Aditya Sathe,Lauren Wideman et al.
Abraham L Almatari et al.
Renal cell carcinoma (RCC) is estimated to account for 4.1% of all new cancer diagnoses and 2.4% of all cancer deaths in 2020 according to the National Cancer Institute SEER database. This will likely total 73,000 new cases and 15,000 death...
Distinguishing lipid-poor angiomyolipoma from renal carcinoma using tumor shape [0.03%]
利用肿瘤形状区分低脂性血管平滑肌脂肪瘤和肾癌
Marshall Strother,Robert N Uzzo,Elizabeth Handorf et al.
Marshall Strother et al.
Objectives: To validate the "overflowing beer sign" (OBS) for distinguishing between lipid-poor angiomyolipoma (AML) and renal cell carcinoma, and to determine whether it improves the detection of lipid-poor AML when adde...
Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database [0.03%]
局部晚期肾细胞癌多脏器联合根治性肾切除的患病率和死亡率:全国手术质量安全改进计划(NSQIP)数据库分析
Kelvin Lim,Carlos Riveros,Sanjana Ranganathan et al.
Kelvin Lim et al.
Introduction: Locally advanced renal cell carcinoma (RCC) can rarely invade into adjacent abdominal viscera without clinical evidence of distant metastases. The role of multivisceral resection (MVR) of involved adjacent o...
Characteristics Contributing to Survival Differences Between Black and White Patients Following Cystectomy [0.03%]
导致黑色人种和白色人种膀胱全切术后生存期差异的因素分析
Shoshana J Rosenzweig,Daniel Ranti,Reza Mehrazin et al.
Shoshana J Rosenzweig et al.
Purpose: Examine patient, tumor, and treatment characteristics effect on the disparity between black and white patients with muscle-invasive bladder cancer (MIBC) who undergo radical cystectomy (RC). ...
Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations [0.03%]
在服务医疗不平等待遇人群的医院系统中,中期和高危前列腺癌患者接受最终治疗的情况及其生存率
David-Dan Nguyen,Muhieddine Labban,Logan Briggs et al.
David-Dan Nguyen et al.
Introduction: Although socioeconomic and racial disparities in prostate cancer (CaP) have been attributed to patient-level and physician-level factors, there is growing interest in investigating the role of the facility o...
Prevalence and Morbidity of Local Treatment-Related Side Effects in Metastatic Prostate Cancer Patients [0.03%]
转移性前列腺癌患者的局部治疗相关副作用的发病率和疾病负担
Daniel Sentana-Lledo,Laura E Dodge,Peter Chang et al.
Daniel Sentana-Lledo et al.
Purpose: Treatment toxicity from surgery radical prostatectomy (RP) or radiation therapy (RT) has been well studied in patients with localized prostate cancer. However, little is known about lingering toxicities in patien...
Low risk is low risk, regardless of race or ethnicity: Outcomes of prostate cancer active surveillance and factors associated with reclassification in a racially diverse cohort [0.03%]
低风险就是低风险,无论种族或族裔:前列腺癌主动监测的结局及其与重新分层相关的因素在一个种族多样化的队列中的情况
Kevin Labagnara,Denzel Zhu,Justin Loloi et al.
Kevin Labagnara et al.
Introduction: Active surveillance (AS) is the standard for very low- and low-risk prostate cancer. Although risk factors for pathologic reclassification while on AS have been identified, results are mixed for non-Hispanic...
Folawiyo Laditi,James Nie,Walter Hsiang et al.
Folawiyo Laditi et al.
Background: The expansion of state Medicaid programs associated with the Affordable Care Act has led to significant increases in insurance coverage for economically vulnerable patients, however barriers to accessing cance...
Preliminary results regarding automated identification of patients with a limited six-month survival prognosis using nursing assessment in uro-oncology patients [0.03%]
基于护理评估的泌尿系统肿瘤患者半年生存期自动化预测的初步研究结果
Carmen Roch,Julian Alexander Kielkopf,Ulrich Stefenelli et al.
Carmen Roch et al.
Introduction: Contrary to current recommendations, palliative co-management of tumor patients often occurs late in daily clinical practice. Palliative care specialist (PCS) co-management should be considered at the latest...